Nucleoside reverse transcriptase inhibitors (NRTIs)

M 2 L N Pill - white capsule-shape, 13mm

Pill with imprint M 2 L N is White, Capsule-shape and has been identified as Lamivudine 150 mg. It is supplied by Mylan Pharmaceuticals Inc.

Lamivudine is used in the treatment of Hepatitis B; HIV Infection; Occupational Exposure; Nonoccupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Lamivudine (Lamivudine [ la-miv-ue-deen ])-M 2 L N-150 mg-White-Capsule-shape

Lamivudine
Generic Name: lamivudine [ la-miv-ue-deen ]
Imprint: M 2 L N
Strength: 150 mg
Color: White
Size: 13.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00378-5169 (Discontinued)
Inactive Ingredients: Hypromelloses, Magnesium stearate, Microcrystalline cellulose, Propylene glycol, Sodium starch glycolate type A potato, Titanium dioxide,
Latest News
Related Drugs